{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:19:41Z","timestamp":1794385181319,"version":"4.9.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11853-y","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:38:38Z","timestamp":1761737918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular epidemiology of high-risk human papillomavirus infection and its predictive factors among women living with HIV in Northeast Ethiopia: a facility-based cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Saleamlak","family":"Sebsibe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genet","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bantamlak","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemane","family":"Eshetu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemu","family":"Gedefie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Erkihun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agumas","family":"Shibabaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"3","key":"11853_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/CEJ.0b013e328364f273","volume":"23","author":"A Asiaf","year":"2014","unstructured":"Asiaf A, Ahmad ST, Mohammad SO, Zargar MA. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. Eur J Cancer Prev. 2014;23(3):206\u201324.","journal-title":"Eur J Cancer Prev"},{"key":"11853_CR2","doi-asserted-by":"crossref","unstructured":"Tommasino M. The human papillomavirus family and its role in carcinogenesis. Seminars in cancer biology. Elsevier; 2014.","DOI":"10.1016\/j.semcancer.2013.11.002"},{"key":"11853_CR3","doi-asserted-by":"crossref","unstructured":"Thompson AB, Flowers LC. Human papillomavirus (HPV). Sexually Transmitted Infections in Adolescence and Young Adulthood: A Practical Guide for Clinicians. 2020:279\u2009\u2013\u200997.","DOI":"10.1007\/978-3-030-20491-4_18"},{"key":"11853_CR4","volume-title":"Clinical virology manual","author":"M Loeffelholz","year":"2020","unstructured":"Loeffelholz M. Clinical virology manual. John Wiley & Sons; 2020."},{"issue":"1","key":"11853_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1\u201317.","journal-title":"Clin Microbiol Rev"},{"key":"11853_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2020.10.034","volume":"497","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Cai X, Shen F, Ma F. HPV post-infection microenvironment and cervical cancer. Cancer Lett. 2021;497:243\u201354.","journal-title":"Cancer Lett"},{"issue":"5","key":"11853_CR7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602\u20138.","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"11853_CR8","first-page":"174","volume":"9","author":"ML Sammarco","year":"2020","unstructured":"Sammarco ML, Tamburro M, Pulliero A, Izzotti A, Ripabelli G. Human papillomavirus infections, cervical cancer and micrornas: an overview and implications for public health. MicroRNA. 2020;9(3):174\u201386.","journal-title":"MicroRNA"},{"key":"11853_CR9","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Ramasubbu K, Banerjee M, Balaji MP, Vinayagam Y, V DR. A systematic review on the molecular and clinical association between human papillomavirus and human immunodeficiency virus co-infection in Head, neck and oral squamous cell carcinoma. Rev Med Virol. 2023:e2462.","DOI":"10.1002\/rmv.2462"},{"issue":"4","key":"11853_CR10","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.3892\/ol.2016.4921","volume":"12","author":"G Barillari","year":"2016","unstructured":"Barillari G, Palladino C, Bacigalupo I, Leone P, Falchi M, Ensoli B. Entrance of the Tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels. Oncol Lett. 2016;12(4):2389\u201394.","journal-title":"Oncol Lett"},{"issue":"2","key":"11853_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3892\/ol.2015.3295","volume":"10","author":"D Song","year":"2015","unstructured":"Song D, Li H, Li H, Dai J. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol Lett. 2015;10(2):600\u20136.","journal-title":"Oncol Lett"},{"issue":"1","key":"11853_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0726-6","volume":"7","author":"K Hlad\u00edkov\u00e1","year":"2019","unstructured":"Hlad\u00edkov\u00e1 K, Kouck\u00fd V, Bou\u010dek J, Laco J, Grega M, Hodek M, et al. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8\u2009+\u2009T cells. J Immunother Cancer. 2019;7(1):1\u201316.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"11853_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10051047","volume":"10","author":"A Perez-Gonzalez","year":"2022","unstructured":"Perez-Gonzalez A, Cachay E, Ocampo A, Poveda E. Update on the epidemiological features and clinical implications of human papillomavirus infection (HPV) and human immunodeficiency virus (HIV) coinfection. Microorganisms. 2022;10(5):1047.","journal-title":"Microorganisms"},{"issue":"10","key":"11853_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/v9100267","volume":"9","author":"PE Gravitt","year":"2017","unstructured":"Gravitt PE, Winer RL. Natural history of HPV infection across the lifespan: role of viral latency. Viruses. 2017;9(10):267.","journal-title":"Viruses"},{"key":"11853_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.virol.2016.03.022","volume":"493","author":"J-M Kriek","year":"2016","unstructured":"Kriek J-M, Jaumdally SZ, Masson L, Little F, Mbulawa Z, Gumbi PP, et al. Female genital tract inflammation, HIV co-infection and persistent mucosal human papillomavirus (HPV) infections. Virology. 2016;493:247\u201354.","journal-title":"Virology"},{"issue":"2","key":"11853_CR16","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","volume":"9","author":"D Stelzle","year":"2021","unstructured":"Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah AS, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Global Health. 2021;9(2):e161\u20139.","journal-title":"Lancet Global Health"},{"issue":"3","key":"11853_CR17","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"11853_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778\u201389.","journal-title":"Int J Cancer"},{"key":"11853_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijid.2020.02.051","volume":"95","author":"O Taku","year":"2020","unstructured":"Taku O, Businge CB, Mdaka ML, Phohlo K, Basera W, Garcia-Jardon M, et al. Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa. Int J Infect Dis. 2020;95:176\u201382.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"11853_CR20","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.1016\/S1470-2045(22)00387-4","volume":"23","author":"I Veljkovikj","year":"2022","unstructured":"Veljkovikj I, Ilbawi AM, Roitberg F, Luciani S, Barango P, Corbex M, et al. Evolution of the joint international atomic energy agency (IAEA), international agency for research on cancer (IARC), and WHO cancer control assessments (imPACT Reviews). Lancet Oncol. 2022;23(10):e459\u201368.","journal-title":"Lancet Oncol"},{"issue":"2","key":"11853_CR21","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191\u2013203.","journal-title":"Lancet Global Health"},{"key":"11853_CR22","first-page":"1","volume":"4","author":"ST Memirie","year":"2018","unstructured":"Memirie ST, Habtemariam MK, Asefa M, Deressa BT, Abayneh G, Tsegaye B, et al. Estimates of cancer incidence in Ethiopia in 2015 using population-based registry data. J Global Oncol. 2018;4:1\u201311.","journal-title":"J Global Oncol"},{"key":"11853_CR23","unstructured":"Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, G\u00f3mez D et al. Human papillomavirus and related diseases report. ICO\/IARC information centre on HPV and cancer (HPV information centre). 2019:307-."},{"key":"11853_CR24","volume-title":"Global cancer observatory: cancer today. Volume 20182020","author":"J Ferlay","year":"2020","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M. Global cancer observatory: cancer today. Volume 20182020. Lyon: International agency for research on cancer; 2020."},{"issue":"2","key":"11853_CR25","first-page":"562","volume":"6","author":"KT Tegegne","year":"2021","unstructured":"Tegegne KT, Assefa AA, Tegegne ET, Tessema MK, Tafese G, Gemeda GA, et al. HIV infection and Pre-Cancerous cervical lesion in ethiopia: A systemic review and Meta-Analysis. J Clin Rev Case Rep. 2021;6(2):562\u20138.","journal-title":"J Clin Rev Case Rep"},{"issue":"14","key":"11853_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10143133","volume":"10","author":"T Dub","year":"2021","unstructured":"Dub T, Le C\u0153ur S, Ngo-Giang-Huong N, Matanasarawut W, Suriyachai P, Saisawat K, et al. Prevalence of high-risk human papillomavirus infections before and after cervical lesion treatment, among women living with HIV. J Clin Med. 2021;10(14):3133.","journal-title":"J Clin Med"},{"issue":"1","key":"11853_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02580-0","volume":"23","author":"TM Dessie","year":"2023","unstructured":"Dessie TM, Kassaw AT, Alen GD. Determinants of precancerous cervical lesion among HIV infected women on ART in Woldia comprehensive specialized hospital northeast Ethiopia. BMC Womens Health. 2023;23(1):458.","journal-title":"BMC Womens Health"},{"issue":"1","key":"11853_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02279-2","volume":"23","author":"T Megersa","year":"2023","unstructured":"Megersa T, Dango S, Kumsa K, Lemma K, Lencha B. Prevalence of high-risk human papillomavirus infections and associated factors among women living with HIV in Shashemene town public health facilities, Southern Ethiopia. BMC Womens Health. 2023;23(1):125.","journal-title":"BMC Womens Health"},{"issue":"2","key":"11853_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149152","volume":"11","author":"CE Bekolo","year":"2016","unstructured":"Bekolo CE, O\u2019Bryan G, Tchago FE, Nangue C, Bekoule PS, Kollo B. Integrating cervical cancer screening with HIV care in Cameroon: comparative risk analysis of cervical disease in HIV-infected women receiving antiretroviral therapy to women in the general population. PLoS ONE. 2016;11(2):e0149152.","journal-title":"PLoS ONE"},{"issue":"11","key":"11853_CR30","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/infdis\/jit090","volume":"207","author":"D Konopnicki","year":"2013","unstructured":"Konopnicki D, Manigart Y, Gilles C, Barlow P, de Marchin J, Feoli F, et al. Sustained viral suppression and higher CD4\u2009+\u2009T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women. J Infect Dis. 2013;207(11):1723\u20139.","journal-title":"J Infect Dis"},{"issue":"7","key":"11853_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181415","volume":"12","author":"YH Aweke","year":"2017","unstructured":"Aweke YH, Ayanto SY, Ersado TL. Knowledge, attitude and practice for cervical cancer prevention and control among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: community-based cross-sectional study. PLoS ONE. 2017;12(7):e0181415.","journal-title":"PLoS ONE"},{"key":"11853_CR32","doi-asserted-by":"crossref","unstructured":"Endale H, Mulugeta T, Habte T. The socioeconomic impact of cervical cancer on patients in ethiopia: evidence from Tikur Anbessa specialized hospital. Cancer Manage Res. 2022:1615\u201325.","DOI":"10.2147\/CMAR.S352389"},{"issue":"6","key":"11853_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5306\/wjco.v6.i6.281","volume":"6","author":"R Catarino","year":"2015","unstructured":"Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices. World J Clin Oncol. 2015;6(6):281.","journal-title":"World J Clin Oncol"},{"key":"11853_CR34","unstructured":"FMOH. Guideline for Cervical Cancer Prevention and Control in Ethiopia. Addis Ababa, Ethiopia: Federal Ministry of Health. 2015. Available from: https:\/\/www.iccp-portal.org\/system\/files\/plans\/Guideline%20Eth%20Final.pdf."},{"key":"11853_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-023-01813-9","author":"A Endalamaw","year":"2023","unstructured":"Endalamaw A, Alganeh H, Azage M, Atnafu A, Erku D, Wolka E. Improving cervical cancer continuum of care towards elimination in Ethiopia: a scoping review. Cancer Causes Control. 2023. https:\/\/doi.org\/10.1007\/s10552-023-01813-9.","journal-title":"Cancer Causes Control"},{"issue":"115","key":"11853_CR36","volume":"1","author":"T Gelibo","year":"2017","unstructured":"Gelibo T, Roets L, Getachew T, Bekele A. Coverage and factors associated with cervical cancer screening: results from a population-based WHO steps study in Ethiopia. Adv Oncol Res Treat. 2017;1(115):2.","journal-title":"Adv Oncol Res Treat"},{"key":"11853_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241284943","volume":"31","author":"AL Bogale","year":"2024","unstructured":"Bogale AL, Ali JH, Sherif ZA. Knowledge and practice of women with HIV on cervical cancer prevention and control and their attributes to utilize the screening services in Ethiopia: a cross sectional study. Cancer Control. 2024;31:10732748241284943.","journal-title":"Cancer Control"},{"key":"11853_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-019-4718-5","volume":"19","author":"AA Assefa","year":"2019","unstructured":"Assefa AA, Astawesegn FH, Eshetu B. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study. BMC Health Serv Res. 2019;19:1\u201311.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"11853_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-024-03174-0","volume":"24","author":"E Worku","year":"2024","unstructured":"Worku E, Yigizaw G, Admassu R, Mekonnen D, Gessessa W, Tessema Z, et al. Prevalence and risk factors associated with precancerous and cancerous cervical lesions among HIV-infected women in University of Gondar specialized comprehensive referral hospital, Northwest Ethiopia: cross-sectional study design. BMC Womens Health. 2024;24(1):322.","journal-title":"BMC Womens Health"},{"issue":"3","key":"11853_CR40","first-page":"4","volume":"13","author":"T Belayneh","year":"2019","unstructured":"Belayneh T, Mitiku H, Weldegebreal F. Precancerous cervical lesion and associated factors among HIV-infected women on ART in Amhara regional State, ethiopia: a hospital-based cross-sectional study. Int J Health Sci. 2019;13(3):4.","journal-title":"Int J Health Sci"},{"issue":"1","key":"11853_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12462-9","volume":"24","author":"YA Ferede","year":"2024","unstructured":"Ferede YA, Tassew WC, Zeleke AM. Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta-analysis. BMC Cancer. 2024;24(1):678.","journal-title":"BMC Cancer"},{"issue":"5","key":"11853_CR42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1542\/peds.2012-3495","volume":"131","author":"LB Finer","year":"2013","unstructured":"Finer LB, Philbin JM. Sexual initiation, contraceptive use, and pregnancy among young adolescents. Pediatrics. 2013;131(5):886\u201391.","journal-title":"Pediatrics"},{"issue":"3","key":"11853_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.15288\/jsad.2015.76.378","volume":"76","author":"RB Goldstein","year":"2015","unstructured":"Goldstein RB, Chou SP, Smith SM, Jung J, Zhang H, Saha TD, et al. Nosologic comparisons of DSM-IV and DSM-5 alcohol and drug use disorders: results from the National epidemiologic survey on alcohol and related conditions\u2013III. J Stud Alcohol Drugs. 2015;76(3):378\u201388.","journal-title":"J Stud Alcohol Drugs"},{"key":"11853_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4706-1","volume":"12","author":"Y Yeshaw","year":"2019","unstructured":"Yeshaw Y, Zerihun MF. Khat chewing prevalence and correlates among university staff in Ethiopia: a cross-sectional study. BMC Res Notes. 2019;12:1\u20136.","journal-title":"BMC Res Notes"},{"key":"11853_CR45","unstructured":"Statistics NCfH. National health and nutrition examination survey. 2017."},{"key":"11853_CR46","doi-asserted-by":"crossref","unstructured":"Dowell D. CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022. MMWR Recommendations and reports. 2022;71.","DOI":"10.15585\/mmwr.rr7103a1"},{"issue":"1","key":"11853_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11928-0","volume":"24","author":"H Nakigozi","year":"2024","unstructured":"Nakigozi H, Ndejjo R, Bazeyo W, Nabaggala A, Achola C, Iga M, et al. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda. BMC Cancer. 2024;24(1):243.","journal-title":"BMC Cancer"},{"issue":"1","key":"11853_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.47430\/ujmr.2491.016","volume":"9","author":"Y Abubakar","year":"2024","unstructured":"Abubakar Y, Ajang A, Ella E, Oguntayo A, Aminu M. Prevalence of human papillomavirus infection and its association with the risk of cervical cancer among HIV-positive women in Plateau State, North-Central Nigeria. UMYU Journal of Microbiology Research (UJMR). 2024;9(1):247\u2013157.","journal-title":"UMYU Journal of Microbiology Research (UJMR)"},{"key":"11853_CR49","doi-asserted-by":"crossref","unstructured":"Miranda AE, Silveira MF, Travassos AG, Tenorio T, do Val ICC, Lannoy L, et al. P3. 13 High-risk papillomavirus infection and cervical cancer among women living with human immunodeficiency virus: Brazilian multicentric study. BMJ Publishing Group Ltd; 2017.","DOI":"10.1136\/sextrans-2017-053264.250"},{"issue":"6","key":"11853_CR50","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1159\/000525340","volume":"66","author":"R Gupta","year":"2022","unstructured":"Gupta R, Hussain S, Hariprasad R, Dhanasekaran K, Verma S, Agarwal V, et al. High prevalence of cervical high-grade lesions and high-risk human papillomavirus infections in women living with HIV: a case for prioritizing cervical screening in this vulnerable group. Acta Cytol. 2022;66(6):496\u2013506.","journal-title":"Acta Cytol"},{"issue":"1","key":"11853_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-024-03249-y","volume":"24","author":"M Abdi","year":"2024","unstructured":"Abdi M, Tamiru A, Tilahun T, Tiruneh G, Fite MB. Factors associated with human papillomavirus infections among women living with HIV in public health facilities in western Oromia, Ethiopia. BMC Womens Health. 2024;24(1):423.","journal-title":"BMC Womens Health"},{"issue":"3","key":"11853_CR52","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1080\/21645515.2020.1799666","volume":"17","author":"C Miguel Haddad Kury","year":"2021","unstructured":"Miguel Haddad Kury C, Santos KCDS, Carestiato FN, Rapozo G, Leandro CG, Fernandes LA, et al. Human papillomavirus prevalence, genomic diversity and related risk factors in HIV-positive women from a countryside city in the state of Rio de Janeiro. Hum Vaccin Immunother. 2021;17(3):838\u201344.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"11853_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174117","volume":"12","author":"HA Kelly","year":"2017","unstructured":"Kelly HA, Ngou J, Chikandiwa A, Sawadogo B, Gilham C, Omar T, et al. Associations of human papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa. PLoS ONE. 2017;12(3):e0174117.","journal-title":"PLoS ONE"},{"issue":"1","key":"11853_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-023-00513-y","volume":"18","author":"PK Akakpo","year":"2023","unstructured":"Akakpo PK, Ken-Amoah S, Enyan NIE, Agyare E, Salia E, Baidoo I, et al. High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting. Infect Agents Cancer. 2023;18(1):33.","journal-title":"Infect Agents Cancer"},{"issue":"5","key":"11853_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0303535","volume":"19","author":"F Agyare Gyane","year":"2024","unstructured":"Agyare Gyane F, Modey E, Maya E, Bonney EY, Abaidoo-Myles A, Paintsil E, et al. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana. PLoS ONE. 2024;19(5):e0303535.","journal-title":"PLoS ONE"},{"issue":"1","key":"11853_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09412-y","volume":"24","author":"B Traore","year":"2024","unstructured":"Traore B, Kassogue Y, Diakite B, Diarra F, Cisse K, Kassogue O, et al. Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study. BMC Infect Dis. 2024;24(1):513.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"11853_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.34172\/ehsj.25209","volume":"10","author":"PN Nantale","year":"2023","unstructured":"Nantale PN, Nyagero J, Kemigisha E. The prevalence of human papillomavirus in women living with HIV in Mukono general hospital, Uganda. Epidemiology and Health System Journal. 2023;10(4):154\u20138.","journal-title":"Epidemiology and Health System Journal"},{"issue":"19","key":"11853_CR58","doi-asserted-by":"publisher","first-page":"10358","DOI":"10.3390\/ijms251910358","volume":"25","author":"G Pavone","year":"2024","unstructured":"Pavone G, Marino A, Fisicaro V, Motta L, Spata A, Martorana F, et al. Entangled connections: HIV and HPV interplay in cervical Cancer\u2014A. Compr Rev Int J Mol Sci. 2024;25(19):10358.","journal-title":"Compr Rev Int J Mol Sci"},{"key":"11853_CR59","doi-asserted-by":"crossref","unstructured":"Okunade KS, Badmos KB, Okoro A, Awolola NA, Nwaokorie FO, Adelabu H et al. Prevalence and Associated Factors of High-Risk Human Papillomavirus Infections among Human Immunodeficiency Virus-Infected Women in Lagos, Nigeria. 2024.","DOI":"10.21203\/rs.3.rs-4645178\/v1"},{"issue":"2","key":"11853_CR60","doi-asserted-by":"publisher","first-page":"e0212516","DOI":"10.1371\/journal.pone.0212516","volume":"14","author":"YT Nyasenu","year":"2019","unstructured":"Nyasenu YT, Gbeasor-Komlanvi FA, Ehlan A, Issa SA-R, Dossim S, Kolou M, et al. Prevalence and distribution of human papillomavirus (HPV) genotypes among HIV infected women in Lom\u00e9, Togo. PLoS ONE. 2019;14(2):e0212516.","journal-title":"PLoS ONE"},{"issue":"1","key":"11853_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02342-y","volume":"23","author":"DW Nang","year":"2023","unstructured":"Nang DW, Tukirinawe H, Okello M, Tayebwa B, Theophilus P, Sikakulya FK, et al. Prevalence of high-risk human papillomavirus infection and associated factors among women of reproductive age attending a rural teaching hospital in Western Uganda. BMC Womens Health. 2023;23(1):209.","journal-title":"BMC Womens Health"},{"issue":"1","key":"11853_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-018-0579-z","volume":"18","author":"AD Nega","year":"2018","unstructured":"Nega AD, Woldetsadik MA, Gelagay AA. Low uptake of cervical cancer screening among HIV positive women in Gondar university referral hospital, Northwest ethiopia: cross-sectional study design. BMC Womens Health. 2018;18(1):87.","journal-title":"BMC Womens Health"},{"issue":"10197","key":"11853_CR63","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","volume":"394","author":"M Drolet","year":"2019","unstructured":"Drolet M, B\u00e9nard \u00c9, P\u00e9rez N, Brisson M, Ali H, Boily M-C, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497\u2013509.","journal-title":"Lancet"},{"issue":"1","key":"11853_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-023-00513-y","volume":"18","author":"PK Akakpo","year":"2023","unstructured":"Akakpo PK, Ken-Amoah S, Enyan NIE, Agyare E, Salia E, Baidoo I, et al. High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting. Infect Agents Cancer. 2023;18(1):1\u201313.","journal-title":"Infect Agents Cancer"},{"key":"11853_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-018-0942-6","volume":"15","author":"MF Teixeira","year":"2018","unstructured":"Teixeira MF, Sabid\u00f3 M, Leturiondo AL, de Oliveira Ferreira C, Torres KL, Benzaken AS. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas. Virol J. 2018;15:1\u201312.","journal-title":"Virol J"},{"key":"11853_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2881-1","volume":"16","author":"K Thorsteinsson","year":"2016","unstructured":"Thorsteinsson K, Storgaard M, Katzenstein TL, Ladelund S, R\u00f8nsholt FF, Johansen IS, et al. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark\u2013the SHADE. BMC Cancer. 2016;16:1\u201313.","journal-title":"BMC Cancer"},{"issue":"9","key":"11853_CR67","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/cid\/cix135","volume":"64","author":"GM Clifford","year":"2017","unstructured":"Clifford GM, Tully S, Franceschi S. Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer. Clin Infect Dis. 2017;64(9):1228\u201335.","journal-title":"Clin Infect Dis"},{"key":"11853_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3982-7","volume":"19","author":"A Ermel","year":"2019","unstructured":"Ermel A, Tonui P, Titus M, Tong Y, Wong N, Ong\u2019echa J, et al. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women. BMC Infect Dis. 2019;19:1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"11853_CR69","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/QAD.0000000000001301","volume":"31","author":"HA Kelly","year":"2017","unstructured":"Kelly HA, Sawadogo B, Chikandiwa A, Segondy M, Gilham C, Lompo O, et al. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV\/AIDS: effect of anti-retroviral therapy. AIDS. 2017;31(2):273\u201385.","journal-title":"AIDS"},{"issue":"4","key":"11853_CR70","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3322\/caac.21616","volume":"70","author":"D Saslow","year":"2020","unstructured":"Saslow D, Andrews KS, Manassaram-Baptiste D, Smith RA, Fontham ET, Group ACSGD. Human papillomavirus vaccination 2020 guideline update: American cancer society guideline adaptation. Cancer J Clin. 2020;70(4):274\u201380.","journal-title":"Cancer J Clin"},{"key":"11853_CR71","doi-asserted-by":"crossref","unstructured":"Mandiriri AM, Pascoe MJ, Shamu T, Lowe S. Cervical human papillomavirus prevalence, risk factors and outcomes in a cohort of HIV-infected women in Harare, Zimbabwe. South Afr J HIV Med. 2020;21(1).","DOI":"10.4102\/sajhivmed.v21i1.1123"},{"key":"11853_CR72","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00404-018-4733-5","volume":"297","author":"H Ye","year":"2018","unstructured":"Ye H, Song T, Zeng X, Li L, Hou M, Xi M. Association between genital Mycoplasmas infection and human papillomavirus infection, abnormal cervical cytopathology, and cervical cancer: a systematic review and meta-analysis. Arch Gynecol Obstet. 2018;297:1377\u201387.","journal-title":"Arch Gynecol Obstet"},{"key":"11853_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-451","volume":"14","author":"M Camargo","year":"2014","unstructured":"Camargo M, Soto-De Leon SC, Munoz M, Sanchez R, Pe\u00f1a-Herrera D, Pineda-Pe\u00f1a AC, et al. Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia. BMC Cancer. 2014;14:1\u201310.","journal-title":"BMC Cancer"},{"key":"11853_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-9378-9-40","volume":"9","author":"JA Sinayobye","year":"2014","unstructured":"Sinayobye JA, Sklar M, Hoover DR, Shi Q, Dusingize JC, Cohen M, et al. Prevalence and risk factors for High-Risk human papillomavirus (hrHPV) infection among HIV-infected and uninfected Rwandan women: implications for hrHPV-based screening in Rwanda. Infect Agents Cancer. 2014;9:1\u201311.","journal-title":"Infect Agents Cancer"},{"key":"11853_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1486-4","volume":"15","author":"JL Castilho","year":"2015","unstructured":"Castilho JL, Levi JE, Luz PM, Cambou MC, Vanni T, de Andrade A, et al. A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil. BMC Cancer. 2015;15:1\u201310.","journal-title":"BMC Cancer"},{"issue":"6","key":"11853_CR76","first-page":"505","volume":"71","author":"PE Castle","year":"2021","unstructured":"Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus. CA Cancer J Clin. 2021;71(6):505\u201326.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"11853_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085429","volume":"9","author":"DN Dames","year":"2014","unstructured":"Dames DN, Blackman E, Butler R, Taioli E, Eckstein S, Devarajan K, et al. High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas. PLoS ONE. 2014;9(1):e85429.","journal-title":"PLoS ONE"},{"issue":"1","key":"11853_CR78","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","volume":"5","author":"H Kelly","year":"2018","unstructured":"Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P, Qiao Y-l, et al. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018;5(1):e45\u201358.","journal-title":"Lancet HIV"},{"key":"11853_CR79","unstructured":"Organization WH. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of dual-stain cytology to triage women after a positive test for human papillomavirus (HPV). World Health Organization; 2024."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11853-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:06:11Z","timestamp":1761739571000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11853-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11853"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11853-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval was obtained from the College of Medicine and Health Science (CMHS\/540\/20\/16) Research Ethics Review Committee (RERC), Wollo University. Permission letters were obtained from public health facilities in Dessie and Kombolcha cities. Moreover, to respect participants\u2019 autonomy and ensure transparency, written informed consent was obtained from each study participant prior to the commencement of the study. They were allowed to interrupt the assessment if they were negatively impacted, and their autonomy and dignity were upheld. The confidentiality of the participant\u2019s information was protected while collecting anonymous data. Furthermore, the Declaration of Helsinki was followed in the conduct of this investigation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1437"}}